Lushan Yu

5PUBLICATIONS
9CO-AUTHORS
Powder and particle technologyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 26, 2026
A Novel Technology Platform for Extracellular Vesicle-Targeted Expression of Drug-Metabolizing Enzymes: Driving CYP3A4 Expression and Secretion via the EABR Motif.

|May 11, 2024
Pharmacodynamic and Toxicity Studies of 6-Isopropyldithio-2'-guanosine Analogs in Acute T-Lymphoblastic Leukemia.

Tiantian Song, Zheming Yu, Qitao Shen

|Jan 17, 2023
Metabolism and pharmacokinetic study of deuterated osimertinib.

Xuyi Zhan, Shaoyin Bao, Xumei Li

|May 28, 2022
Blockade LAT1 Mediates Methionine Metabolism to Overcome Oxaliplatin Resistance under Hypoxia in Renal Cell Carcinoma.

Qingwen Xu, Yuxi Liu, Wen Sun

|May 26, 2017
Response to Comment on "Epigenetic activation of the drug transporter OCT2 sensitizes renal cell carcinoma to oxaliplatin".

Xiaoli Zheng, Yanqing Liu, Qinqin Yu

Pageof 1

Frequent Collaborators

3 joint publications

Su Zeng

1 joint publications

Xiaoli Zheng

1 joint publications

Yanqing Liu

1 joint publications

Hua Wang